X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
humans (20) 20
cancer (18) 18
oncology (16) 16
female (13) 13
middle aged (11) 11
animals (9) 9
chemotherapy (9) 9
male (9) 9
aged (8) 8
cell biology (8) 8
clinical trials (8) 8
adult (7) 7
care and treatment (7) 7
review (7) 7
tumors (7) 7
apoptosis (6) 6
cancer therapies (6) 6
expression (6) 6
health aspects (6) 6
life sciences (6) 6
lung cancer (6) 6
research (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
colorectal cancer (5) 5
hematology, oncology and palliative medicine (5) 5
medical colleges (5) 5
analysis (4) 4
autophagy (4) 4
breast cancer (4) 4
carcinoma, hepatocellular - drug therapy (4) 4
kinases (4) 4
liver neoplasms - drug therapy (4) 4
multidisciplinary sciences (4) 4
niacinamide - analogs & derivatives (4) 4
therapy (4) 4
angiogenesis (3) 3
antineoplastic agents - therapeutic use (3) 3
apoptosis - drug effects (3) 3
autolysosome (3) 3
autophagosome (3) 3
carcinoma (3) 3
cell growth (3) 3
cell line, tumor (3) 3
chaperone-mediated autophagy (3) 3
china (3) 3
deoxyribonucleic acid--dna (3) 3
double-blind (3) 3
double-blind method (3) 3
endothelial growth-factor (3) 3
flux (3) 3
genetic aspects (3) 3
genetic predisposition to disease (3) 3
genetics (3) 3
immunotherapy (3) 3
internal medicine (3) 3
kaplan-meier estimate (3) 3
lc3 (3) 3
leukemia (3) 3
liver cancer (3) 3
lysosome (3) 3
macroautophagy (3) 3
management (3) 3
medical prognosis (3) 3
medicine (3) 3
medicine & public health (3) 3
medicine, research & experimental (3) 3
metastasis (3) 3
neoplasm metastasis (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
p53 (3) 3
phagophore (3) 3
phenylurea compounds - adverse effects (3) 3
prognosis (3) 3
proteins (3) 3
rodents (3) 3
stress (3) 3
studies (3) 3
sunitinib (3) 3
vacuole (3) 3
acute myeloid-leukemia (2) 2
alleles (2) 2
antigens (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
asian continental ancestry group - genetics (2) 2
autophagy - drug effects (2) 2
benzenesulfonates - therapeutic use (2) 2
biochemistry & molecular biology (2) 2
cancer pain (2) 2
cancer-cells (2) 2
cell cycle (2) 2
cell lung-cancer (2) 2
cell survival (2) 2
cells (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, ISBN 074255466X, xi, 204
Book
Urologia Internationalis, ISSN 0042-1138, 06/2009, Volume 82, Issue 4, pp. I - VI
Journal Article
Journal Article
Journal of Forestry Research, ISSN 1007-662X, 6/2010, Volume 21, Issue 2, pp. 207 - 212
During January to February in 2008, severe ice-snows occurred on 2.09 × 106 km2 of south China and caused tremendous damage to the forests. Stem damage and... 
Life Sciences | Cunninghamia lanceolata | ice-snow damage | litter | nutrient | Forestry | crown debris | soil | Ice-snow damage | Soil | Nutrient | Litter | Crown debris
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 777 - 786
Summary Background The results of FASTACT, a randomised, placebo-controlled, phase 2 study, showed that intercalated chemotherapy and erlotinib significantly... 
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | THERAPY | NSCLC | ONCOLOGY | ADENOCARCINOMA | OPEN-LABEL | EGFR | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetic Predisposition to Disease | Lung Neoplasms - enzymology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Administration, Intravenous | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Clinical trials | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Journal Article
Oncology Letters, ISSN 1792-1074, 08/2013, Volume 6, Issue 2, pp. 317 - 322
Telomerase activation is a critical step in human carcinogenesis through the maintenance of telomeres. Telomerase activity is primarily regulated by the human... 
Leukemia | Epigenetic | Human telomerase reverse transcriptase | CANCER-CELLS | leukemia | HISTONE DEACETYLASE INHIBITOR | DNA METHYLATION | epigenetic | CPG ISLAND | C-MYC | ACUTE MYELOID-LEUKEMIA | IMMORTAL CELLS | TRANSCRIPTASE HTERT GENE | LYMPHOCYTIC-LEUKEMIA | ONCOLOGY | human telomerase reverse transcriptase | EXPRESSION
Journal Article
Cancer Cell International, ISSN 1475-2867, 07/2013, Volume 13, Issue 1, pp. 69 - 69
Background: Angiogenesis has been an attractive target for drug therapy. Aloin (AL), an natural compound derived from Aloe barbadensis Miller leaves, has been... 
Angiogenesis | Tumor growth | Colorectal cancer | STAT3 | Aloin | APOPTOSIS | CELLS | VEGF | TUMOR ANGIOGENESIS | BREAST | CHEMOTHERAPY | P53 | ONCOLOGY | Care and treatment | Vascular endothelial growth factor | Analysis | Apoptosis | Cancer | Proteins | Medical research | Rodents | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e97781
Journal Article
Scientific reports, ISSN 2045-2322, 2014, Volume 4, Issue 1, p. 4694
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 619 - 629
Journal Article